We first analyzed the differential expression of 14 CRCGs in five GEO datasets, and the results (Figure 4A,B) displayed that SLC25A5 and CDKN2A were significantly up-regulated in tumor samples. This evidence concerns the gene CDKN2A and neoplasm.